INJ is consolidating within a falling wedge as buyers defend the $4.25-$4.30 support zone, keeping a potential breakout toward $5.80-$5.90 in focus. Meanwhile, Injective is expanding on-chain perpetual markets across stocks, commodities, forex, indexes, and other traditional asset classes.